COVID-19 Booster Study in Healthy Adults in Australia

计划入组 496 人 · 首次发布于 2022 年 12 月 20 日

Phase 3 Study of Novavax Vaccine(s) as Booster Dose After mRNA Vaccines

计划入组 147 人 · 首次发布于 2023 年 5 月 25 日

Concomitant Administration of the Novavax Vaccine and a 20-valent Pneumococcal Conjugate Vaccine in Adults Aged ≥60 Years

计划入组 256 人 · 首次发布于 2023 年 3 月 14 日

SII Bivalent ( Novavax)

SII B.1.617.2 ( Novavax)

SII B.1.351 ( Novavax)

Novavax

United States

Novavax, Inc.

United States

NOVAVAX CZ a.s.

Czech Republic

FDA Halts Novavax's COVID-19 and Influenza Vaccine Trials Due to Safety Concerns

FDA Halts Novavax's Combined COVID-Flu Vaccine Trial After Adverse Event

Novavax Launches Phase 3 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza Vaccines